Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
98.73 -0.69  -0.69% NASDAQ Feb 27, 8:00PM BATS Real time Currency in USD

Synageva BioPharma Price to Book Value:

7.710 for Feb. 27, 2015

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Price to Book Value Chart

Export Data
Save Image

Synageva BioPharma Historical Price to Book Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Feb. 27, 2015 7.710
Feb. 26, 2015 7.764
Feb. 25, 2015 7.923
Feb. 24, 2015 7.791
Feb. 23, 2015 7.984
Feb. 20, 2015 8.001
Feb. 19, 2015 7.254
Feb. 18, 2015 7.111
Feb. 17, 2015 6.972
Feb. 13, 2015 7.034
Feb. 12, 2015 7.152
Feb. 11, 2015 7.132
Feb. 10, 2015 7.400
Feb. 9, 2015 7.288
Feb. 6, 2015 7.342
Feb. 5, 2015 7.678
Feb. 4, 2015 7.178
Feb. 3, 2015 7.418
Feb. 2, 2015 7.661
Jan. 30, 2015 8.125
Jan. 29, 2015 8.493
Jan. 28, 2015 8.132
Jan. 27, 2015 8.446
Jan. 26, 2015 8.527
Jan. 23, 2015 8.383
   
Jan. 22, 2015 8.328
Jan. 21, 2015 8.183
Jan. 20, 2015 8.148
Jan. 16, 2015 7.750
Jan. 15, 2015 7.682
Jan. 14, 2015 7.839
Jan. 13, 2015 7.745
Jan. 12, 2015 7.797
Jan. 9, 2015 7.652
Jan. 8, 2015 7.474
Jan. 7, 2015 7.335
Jan. 6, 2015 6.642
Jan. 5, 2015 7.085
Jan. 2, 2015 6.638
Dec. 31, 2014 6.543
Dec. 30, 2014 5.792
Dec. 29, 2014 5.957
Dec. 26, 2014 5.835
Dec. 24, 2014 5.735
Dec. 23, 2014 5.737
Dec. 22, 2014 6.093
Dec. 19, 2014 6.102
Dec. 18, 2014 6.073
Dec. 17, 2014 6.139
Dec. 16, 2014 5.586

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Get data for
Advertisement

GEVA Price to Book Value Benchmarks

Companies
Ultragenyx Pharmaceutical 8.671
Regado Biosciences 1.890
PTC Therapeutics 10.41

GEVA Price to Book Value Range, Past 5 Years

Minimum 0.7259 Sep 12 2011
Maximum 10.47 Mar 27 2012
Average 4.197

GEVA Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("GEVA", "price_to_book_value")
  • Last 5 data points: =YCS("GEVA", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.